CABA CABALETTA BIO INC
2026Q1 · CUSIP 12674W109 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
107
Δ holders QoQ
+12
Breadth percentile
Top 25%
Whale holders
55
Δ whales
+2
Inst. holding value
$228M
New positions
27
Closed positions
15
Price momentum (1Q)
+11.1%
Put / Call
3/7
Breadth history (34 quarters)
Past Lit Events & Aftermath 5 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2024Q1 | Top 8% | -59.8% | -75.5% |
| 2023Q4 | Top 17% | -46.0% | -78.3% |
| 2023Q3 | Top 14% | +30.2% | -26.1% |
| 2023Q2 | Top 18% | +33.4% | +82.4% |
| 2023Q1 | Top 15% | +0.6% | +43.2% |
Options Sentiment
Put holders
3
QoQ: +2
Call holders
7
QoQ: +3
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-1.78
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Net margin
—
ROE
-169.8%
Debt ratio
30.3%
FCF (TTM)
-$143M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.